AZTR: First ATR-12 Patient Screened [Yahoo! Finance]
Azitra Inc (AZTR)
Company Research
Source: Yahoo! Finance
Azitra, Inc. (NYSE:AZTR) reported second quarter results following a $10 million raise which enabled the company to begin enrolling its ATR-12 Phase Ib trial for Netherton Syndrome. Just days after the 2Q:24 report, the company announced that the first patient for the ATR-12 trial had been screened and scheduled to initiate treatment before the end of August. A few days later, the company announced that its ATR-04 investigational new drug (IND) application for EGFRi-related skin rash was cleared by the FDA. A Phase I/II study is planned for year-end 2024. Year to date, Azitra has been granted several patents for its ATR-12 and ATR-04 candidates, presented at numerous conferences and strengthened its balance sheet in order to advance its engineered bacterial candidates in dermatology. We recently initiated on Azitra providing a review of Netherton Syndrome, the competitive environment and factors impacting and contributing to our valuation of the enterprise. Below we provide a summa
Show less
Read more
Impact Snapshot
Event Time:
AZTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZTR alerts
High impacting Azitra Inc news events
Weekly update
A roundup of the hottest topics
AZTR
News
- AZTR: Planning 2nd Site for ATR-12 Trial [Yahoo! Finance]Yahoo! Finance
- Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates [Yahoo! Finance]Yahoo! Finance
- Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business UpdatesPR Newswire
- Azitra to Present at BIO-Europe 2024Business Wire
- Azitra to Participate in the 2024 Maxim Healthcare Virtual SummitBusiness Wire
AZTR
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/13/24 - Form 8-K
- AZTR's page on the SEC website